1,3,4,6-Tetra-O-acetyl-2-(2′,3′,4′-tri-O-benzoyl-α-L-fucopyranosyl)-α-D-galactopyranose (CAS 56889-55-5)

1,3,4,6-Tetra-O-acetyl-2-(2′,3′,4′-tri-O-benzoyl-α-L-fucopyranosyl)-α-D-galactopyranose plays a pivotal role in carbohydrate chemistry research, serving as a key intermediate in the synthesis of complex oligosaccharides and glycoconjugates. Its mechanism of action primarily involves its function as a protecting group, shielding specific hydroxyl groups on the galactopyranose and fucopyranosyl moieties. This protection enables chemists to selectively manipulate other hydroxyl groups on the sugar molecules, facilitating the controlled assembly of complex carbohydrate structures. Researchers employ this compound extensively in the synthesis of oligosaccharide fragments for investigating glycan-protein interactions, such as those involved in cell adhesion, signaling, and immune recognition. By strategically removing the acetyl and benzoyl protecting groups, scientists can generate diverse oligosaccharide analogs resembling natural glycans found on cell surfaces and glycoproteins. Furthermore, 1,3,4,6-Tetra-O-acetyl-2-(2′,3′,4′-tri-O-benzoyl-α-L-fucopyranosyl)-α-D-galactopyranose has been instrumental in the preparation of glycoconjugates for various research applications, including vaccine development and glycan microarray technology. Conjugation of synthetic oligosaccharides to carrier proteins allows for the production of glycoconjugate vaccines against pathogens and the probing of glycan-protein interactions on a high-throughput scale. Overall, this compound serves as a valuable tool for carbohydrate synthesis, enabling investigations into the roles of glycans in biological processes and the development of carbohydrate-based research tools.